Navigating Legal Minefields for Independent Pharmacies | Dae Lee, PharmD & Adam Farkas, Attys Buchanan Ingersoll & Rooney PC
I sat down with attorneys Dae Lee and Adam Farkas to dig into the legal mess surrounding GLP-1 compounding, PBM overreach, and the brutal reality facing independent pharmacies. Dae’s a pharmacist-attorney, Adam’s a legal powerhouse, and together they’re helping pharmacies fight back in a system sta…
He Sues Big Pharma Middlemen; Attorney Exposes PBM Corruption | Broken Healthcare Podcast #53
In this explosive episode of Broken Healthcare, host Ray Kober sits down with Dae Lee—a PharmD, attorney, and certified pharmacy benefit specialist—who is on the front lines of one of healthcare’s biggest battles: taking on the 3 powerful PBMs (Pharmacy Benefit Managers) that control 80% of U.S. pr…
From Biotech Startup to Stock Market | Paul Romness, MHA, Health Policy OS Therapies, CEO
Can a small biotech change cancer care—and turn a profit? Paul Romness, CEO of OS Therapies, shares how his five-person team took on one of the deadliest pediatric cancers, went public, and might just shake up the system. From biologics to Wall Street, this one’s got it all. Sponsored by Dae Lee of…
Pharmacies v manufacturers
Send us Fan Mail
In this episode, Darshan Kulkarni speaks with Dae Lee about the growing conflict between pharmaceutical manufacturers and pharmacy benefit managers (PBMs) — and how it’s reshaping the U.S. drug supply chain.
They unpack the recent dispute involving AstraZeneca, which alleges discre…
Independent Pharmacies’ Current Hope for State, Federal PBM Reform
Dae Lee, PharmD, Esq, CPBS, and Lucas Morgan, Esq, joined Over the Counter to discuss both state and federal PBM reform heading into the new year.
Inside the PBM Machine: PBM Audits, Compounding, TrumpRx
Send us Fan Mail
Schedule an Rx Assessment
What happens when GLP-1 compounding, TrumpRx, and PBM audits all collide in your pharmacy?In this episode of the Bottom Line Pharmacy Podcast, hosts Austin Murray and Bonnie Bond, CPA, are joined by healthcare attorney Dae Lee of Buchanan, Ingersoll, & Roo…
The TrumpRx Playbook for Independent Pharmacies - with MatchRX | TWIRx
Up first, Inspirogene-by-McKesson with Joe DePinto
InspiroGene" is a dedicated business unit launched by McKesson in October 2024, focused solely on supporting the commercialization of cell and gene therapies (CGTs). It leverages McKesson's expertise in supply chain, logistics, and specialty phar…
The TrumpRx Playbook for Independent Pharmacies - with MatchRX | TWIRx
Up first, Inspirogene-by-McKesson with Joe DePinto
InspiroGene" is a dedicated business unit launched by McKesson in October 2024, focused solely on supporting the commercialization of cell and gene therapies (CGTs). It leverages McKesson's expertise in supply chain, logistics, and specialty phar…
Maximum Fair Price, the IRA, and What DC Means for 2026 and Beyond | Framework Focus
In this episode of Framework Focus, Dr. Dae Lee breaks down the regulatory and reimbursement shifts reshaping long-term care (LTC) pharmacy. With the Inflation Reduction Act (IRA) moving from policy theory to operational reality, Medicare’s Maximum Fair Price (MFP) program, Part D redesign, and inf…
Peptides, Policy, and PBMs: 2026 Quarter 3 Pharmacy Update with Annie West and Dae Lee
Send us Fan Mail
Schedule an Rx AssessmentA LOT has happened recently in the Peptide market, but what exactly is new with peptides, the FDA, and the future of independent pharmacy? On this episode of the Bottom Line Pharmacy Podcast, we're joined for our typical quarterly pharmacy update with @at…
MOTOR DE BÚSQUEDA DE PODCAST
Puede utilizar nuestro sitio web para buscar podcasts de3,825,319y episodios de195,838,539por personas, lugares o temas.
I have no special talent. I am only passionately curious, and
I listen to podcasts.
‐ Albert "Llamacorn" Einstein
EDITAR
Gracias por ayudar a mantener actualizada la base de datos de podcasts.
